MRSN - Mersana Therapeutics, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6566
Avg. Estimate-0.38-0.38-0.63-1.51
Low Estimate-0.41-0.44-0.72-1.84
High Estimate-0.36-0.33-0.37-1.21
Year Ago EPS-0.970.7-2.79-0.63
Revenue EstimateCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
No. of Analysts6466
Avg. Estimate290k460k42.36M1.42M
Low EstimateN/AN/A42MN/A
High Estimate1M1M43.1M4M
Year Ago Sales1.19M41.03M10.59M42.36M
Sales Growth (year/est)-75.60%-98.90%299.80%-96.60%
Earnings History12/30/20183/30/20196/29/20199/29/2019
EPS Est.-0.69-0.02-0.38-0.37
EPS Actual-0.970.7-0.36-0.35
Difference-0.280.720.020.02
Surprise %-40.60%3,600.00%5.30%5.40%
EPS TrendCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Current Estimate-0.38-0.38-0.63-1.51
7 Days Ago-0.38-0.38-0.63-1.51
30 Days Ago-0.38-0.38-0.58-1.49
60 Days Ago-0.38-0.38-0.58-1.42
90 Days Ago-0.38-0.39-0.57-1.46
EPS RevisionsCurrent Qtr. (Dec 2019)Next Qtr. (Mar 2020)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/A1
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 DaysN/AN/AN/AN/A
Growth EstimatesMRSNIndustrySectorS&P 500
Current Qtr.60.80%N/AN/AN/A
Next Qtr.-154.30%N/AN/A0.08
Current Year77.40%N/AN/A0.01
Next Year-139.70%N/AN/A0.14
Next 5 Years (per annum)N/AN/AN/A0.08
Past 5 Years (per annum)N/AN/AN/AN/A